Article: Despite verdict, Acadia stock doesn't take hit.(Acadia Pharmaceuticals Inc.)

Acadia Pharmaceuticals, Inc.'s stock has been untainted despite a recent verdict that found the San Diego biotech, including one of its top executives, guilty of sexually harassing a former employee.

However, the company is concerned about the economic impact of the ensuing legal battle, apparent in a Securities and Exchange Commission report filed the day of the verdict. The Aug. 24 decision requires the company to pay $6.1 million to former Acadia scientist Audra Scully, 36. The company's insurance policy, which the firm has said it may use to pay part of its legal costs, is $3 million.

In the first day of trading last week--the first week following the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!